Deltex Medical Group plc (LON:DEMG), the global leader in Oesophageal Doppler Monitoring, has told DirectorsTalk that it will be hosting an investor event on 11 September 2017 following the publication
The accuracy and haemodynamic monitoring power of Oesophageal Doppler is legendary. However it sometimes takes the demands of a complex procedure to reinforce the message. One example is Cytoreductive Surgery (CRS) with
Nigel Keen, Deltex Medical’s Chairman LON:DEMG commented: “The improved trends seen in the second half of 2016 have continued into the first half of 2017 and driven a return to
At the Annual General Meeting of Deltex Medical Group plc (LON:DEMG), the global leader in oesophageal Doppler monitoring (ODM), to be held today the Company’s Chairman, Nigel Keen, will make
Deltex Medical Group plc (LON:DEMG), the global leader in Oesophageal Doppler Monitoring (“ODM”), has today announced that it has been granted a new patent. Deltex Medical has been granted patent
Deltex Medical’s Ewan Phillips discusses the highlights of their results for the year-ended 31 December 2016, their grant from the Horizon 2020 programme, new products and what reaching their target number of platform account means for the company in this exclusive interview with DirectorsTalk
Ewan Phillips, Chief Executive Officer of Deltex Medical Group plc (LON:DEMG) tells Proactive Investors they’ve launched a non-invasive High Definition Impedance Cardiography (HD-ICG) module in the UK.
Deltex Medical Group plc (LON:DEMG), the global leader in Oesophageal Doppler Monitoring (“ODM”), gives notice that its Annual Report and Accounts for the year ended 31 December 2016 (“Annual Report
Deltex Medical Group Plc (LON:DEMG) CEO Ewan Phillips talks to DirectorsTalk about its results for the year ended 31st Dec 2016 and also the award of a grant under the
Nigel Keen, Chairman of Deltex Medical LON:DEMG, commented on the results: “2016 was a transitional year for Deltex Medical and our progress means we have entered 2017 with considerable confidence.
© 2024 – DirectorsTalk. All rights reserved. Reproduction in whole or in part, in any form or medium without express written permission is prohibited.
